(Reuters) – Drugstore chain CVS Health Corp said on Monday it was hiring 50,000 employees across the United States to assist patients and customers with the coronavirus outbreak. The new hires would fill in roles ranging from store associates to home delivery ... More »
(Reuters) – CVS Health Corp said on Saturday it will discontinue sales the popular Zantac heartburn treatment and its own generic ranitidine products from its pharmacies after traces of a known carcinogen were found in some of the products by the U.S. Food and... More »
NEW YORK (Reuters) – CVS Health Corp, a top U.S. manager of pharmacy benefits, has added new migraine drugs from Teva Pharmaceutical Industries and Eli Lilly and Co to its list of covered drugs, excluding a rival treatment from Amgen Inc, a CVS spokeswoman tol... More »
Logos of CVS and Aetna are displayed on a monitor above the floor of the New York Stock Exchange shortly after the opening bell in New York, U.S., December 5, 2017. REUTERS/Lucas Jackson NEW YORK (Reuters) – CVS Corp’s proposed purchase of Aetna Inc will affec... More »
U.S. pharmacy operator CVS Health Corp's (CVS.N) move to buy health insurer Aetna Inc (AET.N) could shore-up CVS' vulnerable pharmacy business and spur another round of dealmaking in an industry fearing Amazon's arrival, analysts said. More »
U.S. pharmacy operator CVS Health Corp has made an offer to acquire No. 3 U.S. health insurer Aetna Inc for more than $200 per share, or over $66 billion, people familiar with the matter said on Thursday. More »
CVS Health Corp has paid $5 million to resolve allegations that pharmacies it operates in California failed to keep and maintain accurate records of prescription drugs, the U.S. Justice Department said on Tuesday. More »
CVS Health Corp’s Omnicare unit has agreed to pay $23 million to resolve a long-running whistleblower lawsuit alleging that it took kickbacks from a drugmaker, according to settlement papers released on Friday. More »
We use cookies!
By using this site you agree to the use of cookies, more info.